Literature DB >> 17707555

Examination of host immune resistance against Listeria monocytogenes infection in cyclophosphamide-treated mice after dietary lipid administration.

Lidia Cruz-Chamorro1, María A Puertollano, Elena Puertollano, Gerardo Alvarez de Cienfuegos, Manuel A de Pablo.   

Abstract

BACKGROUND & AIMS: Despite the beneficial effects in the resolution of inflammatory disorders due to their immunosuppressive properties, n-3 polyunsaturated fatty acids are associated with a reduction of immune resistance to some microorganisms. Here, we examine the influence of different dietary lipids on host immune resistance against Listeria monocytogenes in mice treated with cyclophosphamide (CPA).
METHODS: Balb/c mice were fed one of four diets, which contained either olive oil (OO), fish oil (FO), hydrogenated coconut oil (HCO) or low fat (LF) for 4 weeks. Subsequently, mice were treated with CPA or PBS, prior to L. monocytogenes infection. Splenocyte proliferation, survival analysis, counts of viable bacteria from spleens and livers, and measurement of pro-inflammatory cytokine levels were determined.
RESULTS: The FO-rich diet reduced survival, particularly in CPA-treated mice. CPA was responsible for a significant increase of viable bacteria recovery from spleens and livers within each group fed high fat diets, which was aggravated in mice fed an FO diet. In addition, a significant increase of both TNF-alpha and IL-12p70 levels was detected in this group. These results may acquire a crucial relevance in clinical nutrition, particularly when FO diets are administered to immunocompromised patients.
CONCLUSIONS: The mechanism(s) that impair(s) the elimination of L. monocytogenes could be associated with a low mitogen-stimulated splenocyte proliferation, and with an alteration of pro-inflammatory cytokine production. The application of the neutropenic agent CPA moderately aggravates the immunosuppressive state mainly in FO-fed animals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17707555     DOI: 10.1016/j.clnu.2007.06.012

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  7 in total

1.  Effect of Chuanminshen violaceum polysaccharides and its sulfated derivatives on immunosuppression induced by cyclophosphamide in mice.

Authors:  Xinghong Zhao; Yuetian Zhang; Xu Song; Zhongqiong Yin; Renyong Jia; Xingfang Zhao; Xin Lai; Guangxi Wang; Xiaoxia Liang; Changliang He; Lizi Yin; Cheng Lv; Ling Zhao; Gang Shu; Gang Ye; Fei Shi
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 2.  Reducing the burden of obesity-associated cancers with anti-inflammatory long-chain omega-3 polyunsaturated fatty acids.

Authors:  Subreen A Khatib; Emily L Rossi; Laura W Bowers; Stephen D Hursting
Journal:  Prostaglandins Other Lipid Mediat       Date:  2016-07-19       Impact factor: 3.072

3.  Fish oil supplementation reduces maternal defensive inflammation and predicts a gut bacteriome with reduced immune priming capacity in infants.

Authors:  Candice Quin; Deanna M Vollman; Sanjoy Ghosh; Natasha Haskey; Mehrbod Estaki; Jason Pither; Jacqueline A Barnett; Michael N Jay; Blake W Birnie; Deanna L Gibson
Journal:  ISME J       Date:  2020-05-12       Impact factor: 10.302

Review 4.  Immunomodulation by dietary long chain omega-3 fatty acids and the potential for adverse health outcomes.

Authors:  Jenifer I Fenton; Norman G Hord; Sanjoy Ghosh; Eric A Gurzell
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2013-09-30       Impact factor: 4.006

Review 5.  Narrative Review of n-3 Polyunsaturated Fatty Acid Supplementation upon Immune Functions, Resolution Molecules and Lipid Peroxidation.

Authors:  Gary P Zaloga
Journal:  Nutrients       Date:  2021-02-18       Impact factor: 5.717

Review 6.  Dietary fatty acids and immune response to food-borne bacterial infections.

Authors:  Lisa M Harrison; Kannan V Balan; Uma S Babu
Journal:  Nutrients       Date:  2013-05-22       Impact factor: 5.717

7.  Synergistic PA and HA mutations confer mouse adaptation of a contemporary A/H3N2 influenza virus.

Authors:  Mariana Baz; Zeineb M'hamdi; Julie Carbonneau; Sophie Lavigne; Christian Couture; Yacine Abed; Guy Boivin
Journal:  Sci Rep       Date:  2019-11-12       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.